-OECD Digital Tax Project (Global Minimum Tax Implementation) -S. 2003 (Strengthening Benefit Plans Act of 2025) -Implementation of H.R. 1 - One Big Beautiful Bill Act (Corporate/International Provisions)
-H.R.4273 - To amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user fee program for over-the-counter monograph drugs, and for other purposes. -Issues related to the inclusion of ingredients in over-the-counter products -H.R. 1219, Oral Health Products Inclusion Act
- Issues Related to updating the Toxic Substances Control Act (No Bill)
- Issues related to plastics recycling - Issues related to sustainability (no bill) - H.R. 2269/S. 1092 - Wastewater Infrastructure Pollution Prevention and Environmental Safety (WIPPES) Act
-Issues related to FDA review of active ingredients in over-the-counter products
- U.S. Manufacturing Policy and the USMCA - Industrial Machinery Section 232 Investigation - Issues related to America First Trade Policy/IEEPA Tariffs Executive Orders - China 301 Tariffs, Export Controls, Sanctions - Issues Related to the Review of the US-Mexico-Canada Trade Agreement (No Bill) - Personal Protective Equipment and Medical Equipment Section 232 Investigation - Softwood Lumber Section 232 Investigation - Pharmaceuticals Section 232 Investigation - Semiconductors Section 232 Investigation
-Issues Related to Gross Vehicle Weight Limits (no bill)
-Issues related to Asia-Pacific Economic Cooperation (APEC)
- Issues Related to Product Safety and Quality Assurance (No Bill) - FDA Menstrual Products Guidance
-Issues related to Generally Recognized As Safe designation